Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28023706 | 0.77 | MAPT (0.30) | MAPTNPSR1 | |
| SCHEMBL27727248 | 0.77 | MAOA (0.33) | MAPTNPSR1 | |
| SCHEMBL28024161 | 0.77 | MAPT (0.30) | MAPTNPSR1 | |
| SCHEMBL28031694 | 0.73 | MEN1 (0.30) | — | |
| SCHEMBL28032286 | 0.73 | MEN1 (0.30) | NPSR1 | |
| SCHEMBL28032265 | 0.70 | MEN1 (0.31) | — | |
| SCHEMBL28023719 | 0.69 | FADS1 (0.38) | MAPT | |
| SCHEMBL28031660 | 0.69 | ALDH1A1 (0.33) | — | |
| SCHEMBL27932348 | 0.69 | CYP19A1 (0.32) | — | |
| SCHEMBL27992891 | 0.68 | POLB (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103370321-B | Kui Linpyrimido quinoline [1, the 2-b] indazole replaced and the purposes of the conditioning agent as PI3K/AKT approach thereof | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2015-07-29 | — | — | CN | disclosed |
| CN-103459384-A | Benzoxazepines as inhibitors of PI3K/mTOR and methods of their use and manufacture | EXELIXIS INC | 2013-12-18 | — | — | CN | disclosed |
| CN-103370321-A | Substituted pyrimido[1,2-b]indazoles and their use as modulators of the PI3K/AKT pathway | BAYER IP GMBH | 2013-10-23 | — | — | CN | disclosed |